223 related articles for article (PubMed ID: 7536125)
1. Potential benefit of improved local tumor control in patients with prostate carcinoma.
Kuban DA; el-Mahdi AM; Schellhammer PF
Cancer; 1995 May; 75(9):2373-82. PubMed ID: 7536125
[TBL] [Abstract][Full Text] [Related]
2. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.
Perez CA; Michalski J; Brown KC; Lockett MA
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):573-84. PubMed ID: 8948341
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy.
Zagars GK; von Eschenbach AC; Ayala AG
Cancer; 1993 Sep; 72(5):1709-25. PubMed ID: 7688659
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
Zagars GK; Pollack A; von Eschenbach AC
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
[TBL] [Abstract][Full Text] [Related]
5. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
Stromberg J; Martinez A; Benson R; Garton G; Diokno A; Gonzalez J; Zincke H; Schray M; Edmundson G; Brabbins D
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):67-75. PubMed ID: 8270460
[TBL] [Abstract][Full Text] [Related]
6. The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement.
Leibel SA; Fuks Z; Zelefsky MJ; Whitmore WF
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):7-16. PubMed ID: 8270461
[TBL] [Abstract][Full Text] [Related]
7. Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.
Gutt R; Tonlaar N; Kunnavakkam R; Karrison T; Weichselbaum RR; Liauw SL
J Clin Oncol; 2010 Jun; 28(16):2653-9. PubMed ID: 20421534
[TBL] [Abstract][Full Text] [Related]
8. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
9. The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation.
Fuks Z; Leibel SA; Wallner KE; Begg CB; Fair WR; Anderson LL; Hilaris BS; Whitmore WF
Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):537-47. PubMed ID: 1869452
[TBL] [Abstract][Full Text] [Related]
10. Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.
Krauss DJ; Hu C; Bahary JP; Souhami L; Gore EM; Chafe SM; Leibenhaut MH; Narayan S; Torres-Roca J; Michalski J; Zeitzer KL; Donavanik V; Sandler H; McGowan DG; Jones CU; Shipley WU
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):863-73. PubMed ID: 26104939
[TBL] [Abstract][Full Text] [Related]
11. Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma.
Kuban DA; el-Mahdi AM; Schellhammer PF
Urology; 1987 Nov; 30(5):420-6. PubMed ID: 3118547
[TBL] [Abstract][Full Text] [Related]
12. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
MacDonald OK; Schild SE; Vora S; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW
Urology; 2004 Oct; 64(4):760-4. PubMed ID: 15491716
[TBL] [Abstract][Full Text] [Related]
13. Tumor control in definitive irradiation of localized carcinoma of the prostate.
Perez AA; Pilepich MV; Zivnuska F
Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):523-31. PubMed ID: 3700162
[TBL] [Abstract][Full Text] [Related]
14. Definitive external irradiation in stages A (T1) and B (T2) carcinoma of the prostate.
Perez CA; Kirchmann E; Lockett MA
Am J Clin Oncol; 1993 Oct; 16(5):377-88. PubMed ID: 8213619
[TBL] [Abstract][Full Text] [Related]
15. Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate.
Perez CA; Lee HK; Georgiou A; Logsdon MD; Lai PP; Lockett MA
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):581-91. PubMed ID: 8330986
[TBL] [Abstract][Full Text] [Related]
16. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of pelvic recurrence and distant metastasis in prostate carcinoma following definitive radiotherapy.
Lai PP; Perez CA; Lockett MA
Int J Radiat Oncol Biol Phys; 1992; 24(3):423-30. PubMed ID: 1399726
[TBL] [Abstract][Full Text] [Related]
18. Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter.
D'Amico AV; Whittington R; Kaplan I; Beard C; Schultz D; Malkowicz SB; Wein A; Tomaszewski JE; Coleman CN
Cancer; 1998 Jan; 82(2):334-41. PubMed ID: 9445191
[TBL] [Abstract][Full Text] [Related]
19. Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer.
Kupelian PA; Ciezki J; Reddy CA; Klein EA; Mahadevan A
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):16-22. PubMed ID: 17996382
[TBL] [Abstract][Full Text] [Related]
20. Prognosis in patients with local recurrence after definitive irradiation for prostatic carcinoma.
Kuban DA; el-Mahdi AM; Schellhammer PF
Cancer; 1989 Jun; 63(12):2421-5. PubMed ID: 2720588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
